mFast-SeqS-Based Aneuploidy Score in Circulating Cell-Free DNA Is a Prognostic Biomarker in Prostate Cancer

0
69
Scientists investigated the prognostic value of dichotomized aneuploidy scores as well as circulating tumor cell counts in 131 metastatic castration-resistant prostate cancer patients prior to treatment with cabazitaxel.
[Molecular Oncology]
Abstract